Drug firms' funding of advocates often escapes government scrutiny

Many patient groups depend on it, raising tricky ethical questions

By Diedtra Henderson

Globe Staff / March 18, 2007

E-mail|
Reprints|

Text size – +

WASHINGTON -- Elzora K. Brown could stand before a microphone and calmly describe the swath of devastation that cancer has cut through five generations of her family. Her great-grandmother, grandmother, mother, three sisters, and three nieces had breast cancer . And, at age 31 , Brown was diagnosed with the same kind of cancer. (Full article: 1772 words)